EU authorizes Pfizer-BioNTech XFG-adapted COVID vaccine for ages 6 months and upPUBT·11 hours agoPFE-0.40%BNTX+0.54%
BioNTech (BNTX) Stock May Look Fully Priced As Pipeline Hopes BuildSimplywall·Jul 26 at 12:10 AMBNTX+0.54%
BioNTech's next act has nothing to do with COVID. Here's the $500 billion market some investors are ignoringMSN·Jul 23 at 06:41 PMBNTX+0.54%
Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.benzinga_article·Jul 16 at 08:08 AMBNTX+0.54%ABUS-2.72%
Arbutus files patent infringement suits against Pfizer, BioNTech over LNP technologyPUBT·Jul 16 at 06:32 AMABUS-2.72%MRNA-2.36%
Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle GroupGuruFocus·Jul 13 at 11:52 AMCRCL-4.60%DE-4.52%
BioNTech lays commercial groundwork for PD-L1xVEGF via HER2 ADCFiercepharma·Jul 9 at 01:17 PMBNTX+0.54%BMY-0.79%
